-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V2shge3N3XSE4SJ6dFZ6lp8LGUtOj2ba9WyOHL7XA+nVA+hdTkNFQ+kGphtpkodU bONbWf85txYzq3rz/7weWQ== 0000716054-07-000015.txt : 20070227 0000716054-07-000015.hdr.sgml : 20070227 20070227152135 ACCESSION NUMBER: 0000716054-07-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070226 FILED AS OF DATE: 20070227 DATE AS OF CHANGE: 20070227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRANZLER JAY D CENTRAL INDEX KEY: 0001055666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12943 FILM NUMBER: 07653086 BUSINESS ADDRESS: BUSINESS PHONE: 8584522323 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYPRESS BIOSCIENCE INC CENTRAL INDEX KEY: 0000716054 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222389839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584522323 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: IMRE CORP DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-02-26 0000716054 CYPRESS BIOSCIENCE INC CYPB 0001055666 KRANZLER JAY D 4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121 1 1 0 0 CEO Common Stock 2007-02-26 4 S 0 300 7.94 D 188024 I By Trust Common Stock 2007-02-26 4 S 0 138 7.95 D 187886 I By Trust Common Stock 2007-02-26 4 S 0 362 7.96 D 187524 I By Trust Common Stock 2007-02-26 4 S 0 100 7.97 D 187424 I By Trust Common Stock 2007-02-26 4 S 0 700 7.98 D 186724 I By Trust Common Stock 2007-02-26 4 S 0 1000 7.99 D 185724 I By Trust Common Stock 2007-02-26 4 S 0 400 8.01 D 185324 I By Trust Common Stock 2007-02-26 4 S 0 100 8.02 D 185224 I By Trust Common Stock 2007-02-26 4 S 0 300 8.03 D 184924 I By Trust Common Stock 2007-02-26 4 S 0 500 8.04 D 184424 I By Trust Common Stock 2007-02-26 4 S 0 100 8.06 D 184324 I By Trust Common Stock 2007-02-26 4 S 0 100 8.07 D 184224 I By Trust Common Stock 2007-02-26 4 S 0 100 8.08 D 184124 I By Trust Common Stock 2007-02-26 4 S 0 400 8.09 D 183724 I By Trust Common Stock 2007-02-26 4 S 0 100 8.11 D 183624 I By Trust Common Stock 2007-02-26 4 S 0 100 8.12 D 183524 I By Trust Common Stock 2007-02-26 4 S 0 100 8.15 D 183424 I By Trust Common Stock 2007-02-26 4 S 0 100 8.16 D 183324 I By Trust Common Stock 625 D Common Stock 85641 I By 401 (k) plan The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2006. Between January 1, 2007 and February 26, 2007, 12,798 shares of Common Stock were transfered out of the Cypress Bioscience, Inc. 401(k) plan, of which the Reporting Person is the trustee and has voting power over such shares. /s/ Sabrina Martucci Johnson Attorney-in-Fact 2007-02-27 -----END PRIVACY-ENHANCED MESSAGE-----